Krystal Biotech Future Growth
Future criteria checks 5/6
Krystal Biotech is forecast to grow earnings and revenue by 43.6% and 35% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 19.1% in 3 years.
Key information
43.6%
Earnings growth rate
41.0%
EPS growth rate
Biotechs earnings growth | 31.5% |
Revenue growth rate | 35.0% |
Future return on equity | 19.1% |
Analyst coverage | Good |
Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 578 | 252 | 335 | N/A | 6 |
12/31/2025 | 404 | 135 | 230 | 150 | 8 |
12/31/2024 | 260 | 43 | 107 | 72 | 10 |
12/31/2023 | 51 | 11 | -101 | -89 | N/A |
9/30/2023 | 9 | -30 | -119 | -104 | N/A |
6/30/2023 | N/A | -140 | -130 | -102 | N/A |
3/31/2023 | N/A | -135 | -152 | -111 | N/A |
12/31/2022 | N/A | -140 | -154 | -101 | N/A |
9/30/2022 | N/A | -130 | -188 | -99 | N/A |
6/30/2022 | N/A | -115 | -182 | -87 | N/A |
3/31/2022 | N/A | -104 | -137 | -54 | N/A |
12/31/2021 | N/A | -70 | -116 | -48 | N/A |
9/30/2021 | N/A | -58 | -70 | -35 | N/A |
6/30/2021 | N/A | -52 | -52 | -35 | N/A |
3/31/2021 | N/A | -43 | -45 | -30 | N/A |
12/31/2020 | N/A | -32 | -41 | -26 | N/A |
9/30/2020 | N/A | -27 | -35 | -25 | N/A |
6/30/2020 | N/A | -22 | -29 | -23 | N/A |
3/31/2020 | N/A | -20 | -28 | -22 | N/A |
12/31/2019 | N/A | -19 | -25 | -19 | N/A |
9/30/2019 | N/A | -17 | -21 | -15 | N/A |
6/30/2019 | N/A | -16 | -18 | -13 | N/A |
3/31/2019 | N/A | -13 | -14 | -10 | N/A |
12/31/2018 | N/A | -11 | -12 | -9 | N/A |
9/30/2018 | N/A | -9 | -9 | -8 | N/A |
6/30/2018 | N/A | -11 | -7 | -7 | N/A |
3/31/2018 | N/A | -10 | -6 | -6 | N/A |
12/31/2017 | N/A | -8 | -4 | -4 | N/A |
9/30/2017 | N/A | -7 | N/A | -3 | N/A |
6/30/2017 | N/A | -2 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4KB's forecast earnings growth (43.6% per year) is above the savings rate (0.7%).
Earnings vs Market: 4KB's earnings (43.6% per year) are forecast to grow faster than the German market (15.4% per year).
High Growth Earnings: 4KB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 4KB's revenue (35% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 4KB's revenue (35% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4KB's Return on Equity is forecast to be low in 3 years time (19.1%).